1.Research progresses of ablation combined with immunotherapy for liver cancer
Shanpeng WANG ; Xianchuang LIU ; Fengwei CHEN ; Rui YU ; Yuangang QIAO
Chinese Journal of Interventional Imaging and Therapy 2025;22(1):75-78
The main treatment methods of liver cancer include surgical resection,TACE,ablation,immunotherapy and liver transplantation,etc.Ablation promotes the death of liver cancer cells to achieve the purpose of anti-tumor.Immunotherapy can reactivate immune cells and generate new immune responses through corresponding pathways,so as to recognize and eliminate liver cancer cells.Combining ablation can synergistically enhance anti-tumor immune effect of immunotherapy for liver cancer.The research progresses of ablation combined with immunotherapy for liver cancer were reviewed in this article.
2.Research progresses of ablation combined with immunotherapy for liver cancer
Shanpeng WANG ; Xianchuang LIU ; Fengwei CHEN ; Rui YU ; Yuangang QIAO
Chinese Journal of Interventional Imaging and Therapy 2025;22(1):75-78
The main treatment methods of liver cancer include surgical resection,TACE,ablation,immunotherapy and liver transplantation,etc.Ablation promotes the death of liver cancer cells to achieve the purpose of anti-tumor.Immunotherapy can reactivate immune cells and generate new immune responses through corresponding pathways,so as to recognize and eliminate liver cancer cells.Combining ablation can synergistically enhance anti-tumor immune effect of immunotherapy for liver cancer.The research progresses of ablation combined with immunotherapy for liver cancer were reviewed in this article.
3. Mechanism of DCLK1 transcriptional regulation in HCC
Xianchuang WU ; Yuxin LIU ; Leilei ZHANG ; Xianchuang WU ; Yuji NIU ; Jinjin HE ; Hui QIAO ; Jinjin HE ; Hui QIAO
Chinese Journal of Clinical Pharmacology and Therapeutics 2023;28(11):1241-1246
AIM: To investigate the molecular mechanism through which DKK1 is transcriptionally regulated in HCC (hepatocellular carcinoma) cells. METHODS: Real time PCR was used to explore whether EGFR was involved in regulating DCLK1 mRNA expression in HCC cells; Western blot assay was used to examine whether EGFR-mediated the up-regulation of DCLK1 protein in HCC cells; Immunohistochemical (IHC) analyses were used to examine the protein expression of EGFR and DCLK1 in 39 human HCC tumor specimens. RESULTS: EGF promoted the expression of DCLK1 mRNA and protein in HepG2 and Huh-7 cells (P<0.05, P<0.01), while knockdown of EGFR with two specific siRNA could reverse EGF-induced the up-regulation of DCLK1 mRNA and protein (P<0.01). IHC analyses revealed that the amount of EGFR correlated significantly with that of DCLK1 (r=0.669 6). CONCLUSION: EGFR promoted DCLK1 transcription in HCC.

Result Analysis
Print
Save
E-mail